← Back to Search

Arteriovenous Graft (AVG) for Arteriovenous Fistula

N/A
Waitlist Available
Led By Theodore Yuo, MD MSc
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test whether it is feasible and safe to randomize patients over 65 years old who start hemodialysis with a tunneled dialysis catheter (TDC) to an arteriovenous fistula (AVF) strategy or to an arteriovenous graft (AVG) strategy. The primary outcome is feasibility, which will be assessed by measuring the proportion of randomized participants who receive the assigned arteriovenous access and the annual rate of enrollment in the study.

Eligible Conditions
  • Arteriovenous Graft
  • Arteriovenous Fistula
  • Kidney Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of subjects that received assigned AV access (AVF vs. AVG)
Secondary outcome measures
Rate of accrual of subjects to the study

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Arteriovenous Graft (AVG)Active Control1 Intervention
If the participant is randomized to the AVG arm of the trial, the surgeon will place a synthetic graft connecting an artery and vein under the skin in an upper extremity.
Group II: Arteriovenous Fistula (AVF)Placebo Group1 Intervention
If the participant is randomized to the AVF arm of the trial, the surgeon will connect an artery to a vein in the upper extremity, without using artificial material as conduit.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,731 Previous Clinical Trials
16,307,415 Total Patients Enrolled
Theodore Yuo, MD MSc4.01 ReviewsPrincipal Investigator - University of Pittsburgh
University of Pittsburgh
~3 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top